First Header Logo Second Header Logo

Connection

Michael Shapiro to Cardiology

This is a "connection" page, showing publications Michael Shapiro has written about Cardiology.
Connection Strength

4.612
  1. Hammoud A, Shapiro MD. Drug Interactions: What Are Important Drug Interactions for the Most Commonly Used Medications in Preventive Cardiology? Med Clin North Am. 2022 Mar; 106(2):389-399.
    View in: PubMed
    Score: 0.733
  2. Mahmood T, Shapiro MD. The Questions on Everyone's Mind: What is and Why Do We Need Preventive Cardiology? Methodist Debakey Cardiovasc J. 2021; 17(4):8-14.
    View in: PubMed
    Score: 0.712
  3. Shapiro MD, Ibanez B. Closing the Glycemic Divide: The Time for Preventive Cardiology Is Now. J Am Coll Cardiol. 2021 Aug 03; 78(5):465-467.
    View in: PubMed
    Score: 0.705
  4. German CA, Shapiro MD. Roadmap to a career in preventive cardiology. Heart. 2021 Sep; 107(17):1435-1436.
    View in: PubMed
    Score: 0.698
  5. Shapiro MD, Maron DJ, Morris PB, Kosiborod M, Sandesara PB, Virani SS, Khera A, Ballantyne CM, Baum SJ, Sperling LS, Bhatt DL, Fazio S. Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives. J Am Coll Cardiol. 2019 10 15; 74(15):1926-1942.
    View in: PubMed
    Score: 0.622
  6. Shapiro MD, Fazio S. Setting the Agenda for Preventive Cardiology. Circ Res. 2017 07 21; 121(3):211-213.
    View in: PubMed
    Score: 0.533
  7. Zhou XD, Cai J, Targher G, Byrne CD, Shapiro MD, Sung KC, Somers VK, Chahal CAA, George J, Chen LL, Zhou Y, Zheng MH. Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention. Cardiovasc Diabetol. 2022 Dec 03; 21(1):270.
    View in: PubMed
    Score: 0.193
  8. Mahmood T, Shapiro MD. Future role of proprotein convertase subtilisin/kexin type 9 inhibitors in preventive cardiology. Curr Opin Cardiol. 2019 09; 34(5):519-525.
    View in: PubMed
    Score: 0.154
  9. Warden BA, Shapiro MD, Fazio S. The Role of the Clinical Pharmacist in a Preventive Cardiology Practice. Ann Pharmacother. 2019 12; 53(12):1214-1219.
    View in: PubMed
    Score: 0.153
  10. Surma S, Shapiro MD, Banach M. Breaking new ground in lipid management: Insights from the 2024 American College of Cardiology Scientific Sessions. Pharmacol Res. 2024 Jul; 205:107246.
    View in: PubMed
    Score: 0.054
  11. Duell PB, Gidding SS, Andersen RL, Knickelbine T, Anderson L, Gianos E, Shrader P, Kindt I, O'Brien EC, McCann D, Hemphill LC, Ahmed CD, Martin SS, Larry JA, Ahmad ZS, Kullo IJ, Underberg JA, Guyton J, Thompson P, Wilemon K, Roe MT, Rader DJ, Cuchel M, Linton MF, Shapiro MD, Moriarty PM, Knowles JW. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry. Atherosclerosis. 2019 10; 289:85-93.
    View in: PubMed
    Score: 0.038
  12. Dodd JD, Maree A, Palacios I, de Moor MM, Mooyaart EA, Shapiro MD, Ferencik M, Brady T, Abbara S, Cury RC, Hoffmann U. Images in cardiovascular medicine. Left main coronary artery compression syndrome: evaluation with 64-slice cardiac multidetector computed tomography. Circulation. 2007 Jan 02; 115(1):e7-8.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.